Transcriptional upregulation of c‐ MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcriptional upregulation of c‐ MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma

Published:2018-11-05 Issue:12 Volume:12 Page:2191-2208
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Hong Jun¹,Maacha Selma¹,Belkhiri Abbes¹

Affiliation:

1. Department of Surgery Vanderbilt University Medical Center Nashville TN USA

Funder

The National Cancer Institute of the National Institutes of Health

Vanderbilt-Ingram Cancer Center

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12395

Reference50 articles.

1. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer

2. Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal Carcinomas

3. Preliminary Clinical Experience with 4’-Epidoxorubicin in Advanced Human Neoplasia

4. Gene of the month: Axl

5. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target;Frontiers in Oncology;2023-07-04

2. AXL in cancer: a modulator of drug resistance and therapeutic target;Journal of Experimental & Clinical Cancer Research;2023-06-16

3. AXL upregulates c‑Myc expression through AKT and ERK signaling pathways in breast cancers;Molecular and Clinical Oncology;2023-02-08

4. AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer;Cancer Discovery;2022-07-27

5. AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma;Frontiers in Oncology;2022-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3